Statin Intervention for Severe Early-Onset Placental Insufficiency: A Randomized Controlled Trial Assessing daily Administration as a Treatment Strategy (STATIN-PRE trial)

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519853-12-00

Acronym

IIBSP-PRE-2024-198

Enrollment

154

Registered

2025-06-13

Start date

2026-01-14

Completion date

Unknown

Last updated

2026-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrauterine growth restriction, preeclampsia

Brief summary

Days of prolongation of pregnancy between inclusion and delivery; continuous (days).

Interventions

DRUGPravastatina Kern Pharma 40 mg comprimidos EFG

DRUGPlacebo Pravastatina

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Days of prolongation of pregnancy between inclusion and delivery; continuous (days).	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026